MGIC Investment Downgraded Amid Foreseen Housing Market Challenges: Analyst

RBC Capital Markets analyst Scott Heleniak downgraded MGIC Investment Corp (NYSE: MTG) to Sector Perform from 

RBC Capital Markets analyst Scott Heleniak downgraded MGIC Investment Corp (NYSE:MTG) to Sector Perform from Outperform at a price target of $17.

The analyst believes MTG shares have neared fair value in the current macro risk/reward environment and expects increasing challenges in the housing market and macro environment.

Heleniak expects the company to witness difficult Y/Y EPS comparisons for Q2 2023 through Q1 2024 owing to high year-ago reserve releases.

Nevertheless, the analyst notes the company has reduced its debt-to-capital ratio to 11.9% from 21% in 2020 and significantly improved capital efficiency and risk management.

Heleniak expects strong earnings & ROEs in H2 2023 and 2024 for the company and significant shareholder returns via buybacks and dividends.

The analyst estimates EPS of $2.10 in 2023 and $2.20 in 2024.

Price Action: MTG shares are trading lower by 1.69% at $15.44 on the last check Thursday.

Total
0
Shares
Related Posts
Read More

Filed On May 19, DiaMedica Therapeutics A Complete Clinical Hold Response With FDA For Clinical Hold On A Phase 2/3 Clinical Trial Of DM199; Response With FDA Requesting Clinical Hold Imposed On Phase 2/3 Clinical Trial Of DM199 For AIS Be Lifted

On May 22, 2023, DiaMedica Therapeutics Inc. (the "Company") announced that the Company filed on May 19, 2023 a complete clinical hold response with the U.S. Food and Drug Administration (the "FDA") requesting that the

DMAC